Veeva Systems Inc. (VEEV)
| Market Cap | 47.75B |
| Revenue (ttm) | 2.97B |
| Net Income (ttm) | 809.93M |
| Shares Out | 163.91M |
| EPS (ttm) | 4.86 |
| PE Ratio | 59.95 |
| Forward PE | 36.63 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 704,755 |
| Open | 295.72 |
| Previous Close | 295.69 |
| Day's Range | 291.35 - 297.81 |
| 52-Week Range | 201.54 - 310.50 |
| Beta | 0.98 |
| Analysts | Buy |
| Price Target | 300.07 (+2.99%) |
| Earnings Date | Dec 4, 2025 |
About VEEV
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple channels and geographies; Veeva PromoMats, an end-to-end content and digital asset management solution; and Veeva Crossix, an analytics platform for pharmaceutical brands. It also provides ... [Read more]
Financial Performance
In 2024, Veeva Systems's revenue was $2.75 billion, an increase of 16.20% compared to the previous year's $2.36 billion. Earnings were $714.14 million, an increase of 35.84%.
Financial StatementsAnalyst Summary
According to 28 analysts, the average rating for VEEV stock is "Buy." The 12-month stock price target is $300.07, which is an increase of 2.99% from the latest price.
News
Veeva Systems Inc. (VEEV) Analyst/Investor Day Transcript
Veeva Systems Inc. (NYSE:VEEV) Analyst/Investor Day October 16, 2025 4:30 PM EDT Company Participants Gunnar Hansen - Director of Investor Relations Peter Gassner - Founder, CEO & Director Brian Van ...
OpenEvidence and Veeva Announce Open Vista Partnership
PLEASANTON, Calif. and MIAMI , Oct. 16, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) and OpenEvidence today announced the formation of a long-term partnership to jointly create and market Open Vist...
Veeva AI Agents to Be Released Across All Veeva Applications
Deep, industry-specific agents planned for availability starting this December PLEASANTON, Calif. , Oct. 14, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva AI Agents are planned...
Big Money Boost – Veeva Up 975% Since 2015
Veeva Systems, Inc. (VEEV) shares soar nearly 1,000% since Big Money's first outlier buy in 2015.
4 Top AI-Powered Healthcare Stocks
Healthcare stocks quietly outperformed the market in the past 30 days as headlines centered on the government shutdown over the extension of Affordable Care Act tax credits for 2026. The AI in healthc...
Final Trades: Veeva Systems, PG&E, Conagra Brands, and EQT
The Investment Committee give you their top stocks to watch for the second half.
How to trade the health care break out
The health care sector up 6.5% in one week. The Investment Committee debate how to trade the space.
Josh Brown's 'Best Stocks in the Market': Veeva Systems
Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's "Halftime Report" to detail his latest stock spotlight.
Industry Research Finds Two-Thirds of Clinical Data Managers and CRAs Believe Current Inefficiencies Put Data Quality at Future Risk
Report shows completing manual data reconciliation, cleaning, and review takes each data manager more than 12 hours per week, per study BALTIMORE , Sept. 29, 2025 /PRNewswire/ -- SCDM 2025 — Two-third...
Veeva to Host Virtual Investor Day on October 16, 2025
PLEASANTON, Calif. , Sept. 25, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will host its investor day virtually on Thursday, October 16, 2025.
Bristol Myers Squibb Commits to Veeva Vault CRM
For next-generation CRM with deep, industry-specific AI agents PLEASANTON, Calif. , Sept. 22, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Bristol Myers Squibb (BMS) has commit...
Gilead Sciences Commits to Veeva Vault CRM
Next generation CRM with deep capabilities and agentic AI PLEASANTON, Calif. , Sept. 10, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Gilead Sciences has committed to Veeva Vau...
Calls of the Day: Abbvie, Vertex, Veeva and Vistra
The Investment Committee discuss the latest Calls of the Day.
Veeva Q2: Outpacing Salesforce's "Kill" Switch
Veeva's Q2 FY26 earnings beat expectations, with 17% YoY revenue growth and raised full-year guidance, supporting a strong growth outlook. I believe Salesforce's commentary on “killing Veeva” is highl...
Veeva Systems: Top-Line Momentum Should Continue To Accelerate
I reiterate my 'Buy' rating on Veeva Systems, driven by accelerating Vault CRM adoption and robust R&D Solutions growth. VEEV's successful enterprise migrations and a 9-to-3 top-20 pharma win advantag...
Veeva Systems Inc. (VEEV) Presents At Citi's 2025 Global Technology, Media And Telecommunications Conference (Transcript)
Veeva Systems Inc. (NYSE:VEEV) Citi's 2025 Global Technology, Media and Telecommunications Conference September 4, 2025 2:10 PM EDT Company Participants Brian Van Wagener - Chief Financial Officer Pa...
Veeva to Present at Upcoming Investor Conference
PLEASANTON, Calif. , Sept. 2, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced participation in the following investor conferences: Citi's 2025 Global TMT Conference, New York, NY.
More Than 450 Companies Drive Speed to Market with Veeva RIM
Advanced regulatory capabilities and new industry partnerships accelerate collaboration with global health authorities PLEASANTON, Calif. , Sept. 2, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) tod...
Veeva Systems Analysts Increase Their Forecasts After Better-Than-Expected Q2 Results
Veeva Systems Inc. VEEV reported better-than-expected earnings for the second quarter on Wednesday.
Veeva Systems: Overall, A Good Q2, With Only A Few Minor Issues
Veeva Systems delivered strong Q2 results, with robust revenue growth and a fortress-like balance sheet, reinforcing its leadership in the biopharma sector. The company resolved its legal dispute with...
Veeva Announces Collaboration with Global Biotech to Further Accelerate Clinical Trial Innovation
PLEASANTON, Calif. , Aug. 28, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced a collaboration with Amgen to advance clinical trial innovation.
Veeva Systems Inc. (VEEV) Q2 2026 Earnings Call Transcript
Veeva Systems Inc. (NYSE:VEEV) Q2 2026 Earnings Conference Call August 27, 2025 5:00 PM ET Company Participants Brian Van Wagener - Chief Financial Officer Gunnar Georg Hansen - Director of Investor ...
Veeva Announces Fiscal 2026 Second Quarter Results
Total Revenues of $789.1M, up 17% Year Over Year Subscription Services Revenues of $659.2M, up 17% Year Over Year PLEASANTON, Calif. , Aug. 27, 2025 /PRNewswire/ -- Veeva Systems Inc. (NYSE: VEEV), a ...
Leaders Come Together to Advance the Industry at Veeva Summit
Alnylam Pharmaceuticals, BeOne Medicines, Intercept Pharmaceuticals, Merck, Pfizer, and Sanofi among biopharmas sharing strategies that set future direction Veeva to showcase innovations, including de...
IQVIA and Veeva Announce Long-term Clinical and Commercial Partnerships and Resolution of All Disputes
RESEARCH TRIANGLE PARK, N.C. & PLEASANTON, Calif.--(BUSINESS WIRE)--IQVIA (NYSE: IQV) and Veeva Systems (NYSE: VEEV) today announced global clinical and commercial partnerships and the complete resolu...